|

BG-68501 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BeiGene1

Indications

  • GastroEsophageal Cancer1
  • TNBC - Triple-Negative Breast Cancer1
  • Hormone Receptor Positive HER-2 Negative Breast Cancer1
  • Endometrial Cancer1
  • Hormone Receptor Positive Breast Cancer1

Newport Beach, California1 trial

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Hoag Memorial Presbyterian

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.